Harnessing regulatory T cells to establish immune tolerance.
Science translational medicine
| Authors | |
| Abstract | Engineered regulatory T (T) cells have emerged as precision therapeutics aimed at inducing immune tolerance while reducing the risks associated with generalized immunosuppression. This Viewpoint highlights the opportunities and challenges for engineered T cell therapies in treating autoimmune and other inflammatory diseases. |
| Year of Publication | 2024
|
| Journal | Science translational medicine
|
| Volume | 16
|
| Issue | 738
|
| Pages | eadm8859
|
| Date Published | 03/2024
|
| ISSN | 1946-6242
|
| DOI | 10.1126/scitranslmed.adm8859
|
| PubMed ID | 38478632
|
| Links |